MEDINET Co., Ltd. (2370.T)

JPY 37.0

(0.0%)

Market Cap (In JPY)

9.78 Billion

Revenue (In JPY)

661.54 Million

Net Income (In JPY)

-1.43 Billion

Avg. Volume

2.99 Million

Currency
JPY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
35.0-57.0
PE
-
EPS
-
Beta Value
0.837
ISIN
JP3920990003
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Kanenao Kubushiro
Employee Count
-
Website
https://www.medinet-inc.co.jp
Ipo Date
2003-10-08
Details
MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. Its solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy. The company also manufactures regenerative medical/investigational and specified cell products. In addition, its value chain solutions include personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management system, quality control and assurance, and technology transfer and process development solutions. Further, the company supports medical institutions, research institutions, and biopharmaceutical companies to conduct immuno-cell therapy. MEDINET Co., Ltd. was incorporated in 1995 and is headquartered in Tokyo, Japan.